Virology

A roundup of major science and tech achievements that flew under the radar in 2022, including new vaccines, advanced solar cells, and more.

While treatments are available for HCV-related infections, they are expensive, hard to access, and do not protect against reinfection.

The risk of death from influenza has declined over time, but globally, hundreds of thousands of people still die from the disease each year.

Some wavelengths of light in a range called far-UVC kill microbes in experiments and appear to be harmless to people.

Moderna is reportedly nearing a deal with the DoD to develop mRNA vaccines for biological threats like Ebola

A nasal vaccine delivered as a booster to mRNA shots might offer better protection against COVID-19 and help stop the virus from spreading.

Pfizer plans to begin the regulatory approval process by the end of the year.

In a new discovery, researchers at the University of Glasgow have observed hybrid viruses capable of infecting lung cells in the lab.

UK drugmaker GSK’s RSV vaccine was nearly 95% effective at preventing severe infection in a phase 3 trial of older adults.

Caused by the Sudan strain of Ebola, current vaccines and therapies approved for Ebola won’t work in Uganda. But these might.